SCHEMBL10270943

SCHEMBL10270943

O=C(COc1ccc2c(c1)OCO2)N(c1ccccc1)C1CCCCC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 5/20 1.00
RAB9A P51151 7/20 0.52
NPC1 O15118 6/20 0.52
SMN1; SMN2 Q16637 5/20 0.52
MEN1 O00255 2/20 0.52
ALDH1A1 P00352 2/20 0.52
KMT2A Q03164 2/20 0.52
KDM4E B2RXH2 1/20 0.52
MITF O75030 1/20 0.52
PAX8 Q06710 1/20 0.52
MAOB P27338 2/20 0.48
MAPT P10636 3/20 0.47
LMNA P02545 2/20 0.47
PKM P14618 1/20 0.47
POLB P06746 1/20 0.47
FKBP1A P62942 1/20 0.46
GAA P10253 1/20 0.46
THRB P10828 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20773543 0.86 TRPM8 (0.76) TRPM8RAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL20773828 0.85 TRPM8 (0.74) TRPM8RAB9ANPC1SMN1; SMN2MEN1
SCHEMBL22074335 0.85 TRPM8 (0.74) TRPM8RAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL5992625 0.83 TRPM8 (0.70) TRPM8RAB9ANPC1SMN1; SMN2MEN1
SCHEMBL10271042 0.83 TRPM8 (0.71) TRPM8RAB9ANPC1SMN1; SMN2MEN1
SCHEMBL22074360 0.81 TRPM8 (0.68) TRPM8RAB9ANPC1SMN1; SMN2MEN1
SCHEMBL5995153 0.80 TRPM8 (0.67) TRPM8RAB9ANPC1SMN1; SMN2MEN1
SCHEMBL2718698 0.80 TRPM8 (0.67) TRPM8RAB9ANPC1SMN1; SMN2MEN1
SCHEMBL5992993 0.80 TRPM8 (0.71) TRPM8RAB9ANPC1SMN1; SMN2MEN1
SCHEMBL5992495 0.79 TRPM8 (0.65) TRPM8RAB9ANPC1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3675809-B1 USE OF PHYSIOLOGICAL COOLING INGREDIENTS AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS BASF SE (DE) 2023-09-27 EP disclosed
WO-2022207944-A9 NOVEL MIXTURES AND USES OF (2E)-3-(1,3-BENZODIOXOL-5-YL)-N-PHENYL-N-(TETRAHYDRO-3-FURANYL)-2-PROPENAMIDE SYMRISE AG (DE) 2022-12-15 WO disclosed
US-11044931-B2 Low molecular weight modulators of the cold menthol receptor TRPM8 and use thereof BASF SE (DE) 2021-06-29 US disclosed
EP-2758041-B1 LOW-MOLECULAR MODULATORS OF THE COLD-MENTHOL RECEPTOR TRPM8 AND USE OF SAME BASF SE (DE) 2021-01-13 EP disclosed
EP-3698779-A1 DETECTION AND USE OF LOW MOLECULAR WEIGHT MODULATORS OF THE COLD MENTHOL RECEPTOR TRPM8 BASF SE (DE) 2020-08-26 EP disclosed
EP-3115045-B1 DETECTION AND USE OF LOW MOLECULAR WEIGHT MODULATORS OF THE COLD MENTHOL RECEPTOR TRPM8 BASF SE (DE) 2020-08-12 EP disclosed
EP-3103447-B1 DETECTION AND USE OF LOW MOLECULAR WEIGHT MODULATORS OF THE COLD MENTHOL RECEPTOR TRPM8 BASF SE (DE) 2020-08-05 EP disclosed
US-20200190052-A1 USE OF PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS, AND COMPOSITIONS COMPRISING SUCH ACTIVE INGREDIENTS BASF SE (DE) 2020-06-18 US disclosed
EP-2501761-B1 USE OF PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS, AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS SYMRISE AG (DE) 2020-06-17 EP disclosed
EP-3663366-A2 USE OF PHYSIOLOGICAL COOLING INGREDIENTS AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS Symrise AG (DE) 2020-06-10 EP disclosed
US-8710096-B2 Detection and use of low molecular-weight modulators of the cold-menthol receptor TRPM8 BASF SE (DE) 2014-04-29 US disclosed
US-8710096-B2 Detection and use of low molecular-weight modulators of the cold-menthol receptor TRPM8 BASF SE (DE) 2014-04-29 US disclosed
WO-2013041621-A1 LOW MOLECULAR WEIGHT MODULATORS OF THE COLD-MENTHOL RECEPTOR TRPM8 AND USE THEREOF BASF SE (DE) 2013-03-28 WO disclosed
US-20120263659-A1 USE OF PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS, AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS BASF SE (DE) 2012-10-18 US disclosed
US-20120263659-A1 USE OF PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS, AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS BASF SE (DE) 2012-10-18 US disclosed
WO-2011061330-A9 USE OF PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS, AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS SYMRISE AG (DE) 2012-01-05 WO disclosed
US-20110145970-A1 DETECTION AND USE OF LOW MOLECULAR-WEIGHT MODULATORS OF THE COLD-MENTHOL RECEPTOR TRPM8 BASF SE (DE) 2011-06-23 US disclosed
US-20110145970-A1 DETECTION AND USE OF LOW MOLECULAR-WEIGHT MODULATORS OF THE COLD-MENTHOL RECEPTOR TRPM8 BASF SE (DE) 2011-06-23 US disclosed
WO-2011061330-A2 USE OF PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS, AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS SYMRISE AG (DE) 2011-05-26 WO disclosed
WO-2010026094-A1 DETECTION AND USE OF LOW MOLECULAR-WEIGHT MODULATORS OF THE COLD-MENTHOL RECEPTOR TRPM8 BASF SE (DE) 2010-03-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11044931-B2 Low molecular weight modulators of the cold menthol receptor TRPM8 and use thereof TRPM8, TRPM7, TRPM2 TRPM8 1/4885RAB9A 2487/4885NPC1 2315/4885
US-20110145970-A1 DETECTION AND USE OF LOW MOLECULAR-WEIGHT MODULATORS OF THE COLD-MENTHOL RECEPTOR TRPM8 TRPM8, TRPM2, TRPM7 TRPM8 1/4885RAB9A 3624/4885NPC1 2241/4885
US-20120263659-A1 USE OF PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS, AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS TRPM8, TRPM7, TRPM2 TRPM8 1/4885RAB9A 2143/4885NPC1 1058/4885
US-20200190052-A1 USE OF PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS, AND COMPOSITIONS COMPRISING SUCH ACTIVE INGREDIENTS TRPM8, TRPM7, TRPM5 TRPM8 1/4885RAB9A 3290/4885NPC1 708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.